...
首页> 外文期刊>Clinical Interventions in Aging >Upregulation of genes related to bone formation by γ-amino butyric acid and γ-oryzanol in germinated brown rice is via the activation of GABAB-receptors and reduction of serum IL-6 in rats
【24h】

Upregulation of genes related to bone formation by γ-amino butyric acid and γ-oryzanol in germinated brown rice is via the activation of GABAB-receptors and reduction of serum IL-6 in rats

机译:γ-氨基丁酸和γ-谷维素在发芽糙米中与骨形成相关的基因上调是通过激活GABAB受体和降低大鼠血清IL-6来实现的

获取原文

摘要

Background: Osteoporosis and other bone degenerative diseases are among the most challenging non-communicable diseases to treat. Previous works relate bone loss due to osteoporosis with oxidative stress generated by free radicals and inflammatory cytokines. Alternative therapy to hormone replacement has been an area of interest to researchers for almost three decades due to hormone therapy-associated side effects. Methods: In this study, we investigated the effects of gamma-amino butyric acid (GABA), gamma-oryzanol (ORZ), acylated steryl glucosides (ASG), and phenolic extracts from germinated brown rice (GBR) on the expression of genes related to bone metabolism, such as bone morphogenic protein-2 (BMP-2), secreted protein acidic and rich in cysteine (SPARC), runt-related transcription factor 2 (RUNX-2), osteoblast-specific transcription factor osterix (Osx), periostin, osteoblast specific factor (Postn), collagen 1&2 (Col1&2), calcitonin receptor gene (CGRP); body weight measurement and also serum interleukin-6 (IL-6) and osteocalcin, in serum and bone. Rats were treated with GBR, ORZ, GABA, and ASG at (100 and 200 mg/kg); estrogen (0.2 mg/kg), or remifemin (10 and 20 mg/kg), compared to ovariectomized non-treated group as well as non-ovariectomized non-treated (sham) group. Enzyme-linked immunosorbent assay was used to measure the IL-6 and osteocalcin levels at week 2, 4, and 8, while the gene expression in the bone tissue was determined using the Genetic Analysis System (Beckman Coulter Inc, Brea, CA, USA). Results: The results indicate that groups treated with GABA (100 and 200 mg/kg) showed significant upregulation of SPARC, calcitonin receptor, and BMP-2 genes (P < 0.05), while the ORZ-treated group (100 and 200 mg/kg) revealed significant (P < 0.05) upregulation of Osx, Postn, RUNX-2, and Col1&2. Similarly, IL-6 concentration decreased, while osteocalcin levels increased significantly (P < 0.05) in the treated groups as compared to ovariectomized non-treated groups. Conclusion: GABA and ORZ from GBR stimulates osteoblastogenesis by upregulation of bone formation genes, possibly via the activation of GABAB receptors and by inhibiting the activity of inflammatory cytokines and reactive oxygen species. Therefore, it could be used effectively in the management of osteoporosis.
机译:背景:骨质疏松症和其他骨骼变性疾病是最具挑战性的非传染性疾病。先前的工作将骨质疏松症导致的骨质流失与自由基和炎性细胞因子产生的氧化应激相关。由于激素治疗相关的副作用,替代激素替代治疗已成为研究人员近三十年来的研究热点。方法:在这项研究中,我们调查了γ-氨基丁酸(GABA),γ-谷维素醇(ORZ),酰化的甾基糖苷(ASG)和发芽糙米(GBR)的酚提取物对相关基因表达的影响对骨代谢的影响,例如骨形态发生蛋白2(BMP-2),酸性且富含半胱氨酸的分泌蛋白(SPARC),矮子相关转录因子2(RUNX-2),成骨细胞特异性转录因子osterix(Osx),骨膜素,成骨细胞特异性因子(Postn),胶原蛋白1&2(Col1&2),降钙素受体基因(CGRP);体重测量以及血清和骨骼中的血清白介素6(IL-6)和骨钙素。用GBR,ORZ,GABA和ASG分别以100和200 mg / kg的剂量治疗大鼠;与未切除卵巢的未治疗组和未切除卵巢的非治疗(假)组相比,雌激素(0.2 mg / kg)或瑞非明(10和20 mg / kg)。使用酶联免疫吸附测定法在第2、4和8周测量IL-6和骨钙素水平,同时使用遗传分析系统(Beckman Coulter Inc,Brea,CA,USA)确定骨组织中的基因表达。 )。结果:结果表明,GABA(100和200 mg / kg)治疗组显示SPARC,降钙素受体和BMP-2基因显着上调(P <0.05),而ORZ治疗组(100和200 mg / kg kg)显示Osx,Postn,RUNX-2和Col1&2显着(P <0.05)上调。同样,与未切除卵巢的未治疗组相比,治疗组的IL-6浓度降低,而骨钙素水平显着增加(P <0.05)。结论:GBR中的GABA和ORZ可通过上调骨形成基因(可能是通过激活GABAB受体并抑制炎性细胞因子和活性氧的活性)来刺激成骨细胞生成。因此,可以有效地用于骨质疏松症的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号